Study Of Sumatriptan Succinate Injection Kit In Patients With Migraine or Cluster Headache In Japan
This study will be conducted to collect cases treated by self-injection of sumatriptan 3mg
kit product for the treatment of migraine or cluster headache attacks in clinical settings,
to demonstrate the efficacy, and to examine patient acceptability (simplicity and
usefulness) and rate of successful self-injection.
A Study of Combination Product (Sumatriptan Succinate and Naproxen Sodium) in Migraine Subjects Who Report Poor Response or Intolerance to Short Acting Triptans (Study 2 of 2)
This is a randomized, double-blind, placebo-controlled, crossover, two-attack, out-patient,
early-intervention evaluation of subjects who have migraine with or without aura and who
discontinued use of short acting triptan(s) within the past year due to non-response or
intolerance. Subjects will treat 2 separate migraine attacks during the mild phase of each
attack; one attack will be treated with one tablet of the Combination Product (sumatriptan
succinate and naproxen sodium) and the other attack with one tablet of placebo (crossover
design). [Study 2 of 2]
Serving leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.